| scholarly article | Q13442814 |
| P819 | ADS bibcode | 2014PLoSO...9j6867Z |
| P356 | DOI | 10.1371/JOURNAL.PONE.0106867 |
| P932 | PMC publication ID | 4167552 |
| P698 | PubMed publication ID | 25229627 |
| P5875 | ResearchGate publication ID | 265735058 |
| P50 | author | Alexander Kabanov | Q4206547 |
| P2093 | author name string | Richa Gupta | |
| Elena V Batrakova | |||
| Yuling Zhao | |||
| Zhijian He | |||
| John P Bohnsack | |||
| Matthew J Haney | |||
| P2860 | cites work | Specific transfection of inflamed brain by macrophages: a new therapeutic strategy for neurodegenerative diseases | Q21133553 |
| Functional recovery in parkinsonian monkeys treated with GDNF | Q24312738 | ||
| Glial-derived neurotrophic factor gene transfer for Parkinson's disease: anterograde distribution of AAV2 vectors in the primate brain | Q27002651 | ||
| Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells | Q27860960 | ||
| Improvement of bilateral motor functions in patients with Parkinson disease through the unilateral intraputaminal infusion of glial cell line-derived neurotrophic factor | Q28237467 | ||
| Protection and repair of the nigrostriatal dopaminergic system by GDNF in vivo | Q28306009 | ||
| Distinct structural elements in GDNF mediate binding to GFRalpha1 and activation of the GFRalpha1-c-Ret receptor complex | Q28909781 | ||
| Membrane vesicles as conveyors of immune responses | Q29547765 | ||
| Isolation and characterization of exosomes from cell culture supernatants and biological fluids | Q29615035 | ||
| Identification of two distinct macrophage subsets with divergent effects causing either neurotoxicity or regeneration in the injured mouse spinal cord | Q29619388 | ||
| Macrophage-mediated GDNF delivery protects against dopaminergic neurodegeneration: a therapeutic strategy for Parkinson's disease | Q30496234 | ||
| Interleukin-1beta -induced changes in blood-brain barrier permeability, apparent diffusion coefficient, and cerebral blood volume in the rat brain: a magnetic resonance study. | Q30618539 | ||
| Localized striatal delivery of GDNF as a treatment for Parkinson disease | Q31038741 | ||
| Dissociation between short-term increased graft survival and long-term functional improvements in Parkinsonian rats overexpressing glial cell line-derived neurotrophic factor. | Q31134033 | ||
| Macrophages offer a paradigm switch for CNS delivery of therapeutic proteins. | Q33631069 | ||
| A women's health issue: Alzheimer's disease and strategies for maintaining cognitive health. | Q33739911 | ||
| Macrophage delivery of therapeutic nanozymes in a murine model of Parkinson's disease | Q33892744 | ||
| Structural pathways for macromolecular and cellular transport across the blood-brain barrier during inflammatory conditions. Review | Q34306352 | ||
| Response of aged parkinsonian monkeys to in vivo gene transfer of GDNF | Q34339833 | ||
| Chemokine targets in acute brain injury and disease. | Q34361372 | ||
| Neuroprotective peptide drug delivery and development: potential new therapeutics | Q34446019 | ||
| Polyelectrolyte complex optimization for macrophage delivery of redox enzyme nanoparticles. | Q34566992 | ||
| Activated T cells recruit exosomes secreted by dendritic cells via LFA-1 | Q82876007 | ||
| Induction and expression of abnormal involuntary movements is related to the duration of dopaminergic stimulation in 6-OHDA-lesioned rats | Q84201812 | ||
| Cell-mediated drug delivery. | Q34709440 | ||
| Enzyme replacement and enhancement therapies: lessons from lysosomal disorders | Q35013195 | ||
| Cell-mediated transfer of catalase nanoparticles from macrophages to brain endothelial, glial and neuronal cells. | Q35194750 | ||
| Active Targeted Macrophage-mediated Delivery of Catalase to Affected Brain Regions in Models of Parkinson's Disease | Q35702733 | ||
| The Jeanne Manery-Fisher Memorial Lecture 1991. Maturation of reticulocytes: formation of exosomes as a mechanism for shedding membrane proteins | Q35777208 | ||
| Microglial and astrocyte chemokines regulate monocyte migration through the blood-brain barrier in human immunodeficiency virus-1 encephalitis | Q35788126 | ||
| Ex vivo nerve growth factor gene transfer to the basal forebrain in presymptomatic middle-aged rats prevents the development of cholinergic neuron atrophy and cognitive impairment during aging | Q35894004 | ||
| D-beta-hydroxybutyrate rescues mitochondrial respiration and mitigates features of Parkinson disease | Q35919815 | ||
| The role of iNOS in chronic inflammatory processes in vivo: is it damage-promoting, protective, or active at all? | Q35972273 | ||
| Blood-borne macrophage-neural cell interactions hitchhike on endosome networks for cell-based nanozyme brain delivery. | Q36063039 | ||
| Exosomes released from macrophages infected with intracellular pathogens stimulate a proinflammatory response in vitro and in vivo | Q36384832 | ||
| Genetics of Parkinson disease: paradigm shifts and future prospects. | Q36423921 | ||
| Intrastriatal injection of an adenoviral vector expressing glial-cell-line-derived neurotrophic factor prevents dopaminergic neuron degeneration and behavioral impairment in a rat model of Parkinson disease. | Q36561684 | ||
| Bone marrow-derived microglia-based neurturin delivery protects against dopaminergic neurodegeneration in a mouse model of Parkinson's disease | Q36819317 | ||
| A macrophage-nanozyme delivery system for Parkinson's disease | Q37179637 | ||
| Developmentally regulated mannose 6-phosphate receptor-mediated transport of a lysosomal enzyme across the blood-brain barrier | Q37494188 | ||
| Trophic factors therapy in Parkinson's disease | Q37574424 | ||
| Use of growth factors for the treatment of Parkinson's disease | Q37762259 | ||
| Toward tailored exosomes: the exosomal tetraspanin web contributes to target cell selection. | Q39326204 | ||
| Erythropoietin and GDNF enhance ventral mesencephalic fiber outgrowth and capillary proliferation following neural transplantation in a rodent model of Parkinson's disease | Q40244617 | ||
| Regulatable acetylcholine-producing fibroblasts enhance cognitive performance | Q40368732 | ||
| Induction of heat shock proteins in B-cell exosomes. | Q40392853 | ||
| Neurorescue effects of VEGF on a rat model of Parkinson's disease | Q40393076 | ||
| Glial cell line-derived neurotrophic factor increases stimulus-evoked dopamine release and motor speed in aged rhesus monkeys. | Q40664960 | ||
| Randomized, double-blind trial of glial cell line-derived neurotrophic factor (GDNF) in PD. | Q40678042 | ||
| Neuroprotective effects of IGF-I against TNFalpha-induced neuronal damage in HIV-associated dementia | Q40680601 | ||
| Delayed delivery of AAV-GDNF prevents nigral neurodegeneration and promotes functional recovery in a rat model of Parkinson's disease | Q40737427 | ||
| Neuroprotection through delivery of glial cell line-derived neurotrophic factor by neural stem cells in a mouse model of Parkinson's disease. | Q40776566 | ||
| Outwitting the blood-brain barrier for therapeutic purposes: osmotic opening and other means | Q40859254 | ||
| Inflammation in the nervous system | Q40958003 | ||
| Human nerve growth factor prevents degeneration of basal forebrain cholinergic neurons in primates | Q41137321 | ||
| Ex vivo gene transfer of brain-derived neurotrophic factor to the intact rat forebrain: neurotrophic effects on cholinergic neurons. | Q41207167 | ||
| Glial cell line-derived neurotrophic factor augments midbrain dopaminergic circuits in vivo. | Q41397008 | ||
| The selective binding and transmigration of monocytes through the junctional complexes of human endothelium | Q42204858 | ||
| Exosomes: Fit to deliver small RNA. | Q42380535 | ||
| Ciliary neurotrophic factor cell-based delivery prevents synaptic impairment and improves memory in mouse models of Alzheimer's disease. | Q43641040 | ||
| Enhanced vascularization and survival of neural transplants with ex vivo angiogenic gene transfer. | Q43822016 | ||
| Brain-derived neurotrophic factor is neuroprotective against human immunodeficiency virus-1 envelope proteins | Q45423762 | ||
| Increased host neuronal survival and motor function in BMT Parkinsonian mice: involvement of immunosuppression | Q46687888 | ||
| Brain-derived growth factor and nerve growth factor concentrations are decreased in the substantia nigra in Parkinson's disease | Q48132256 | ||
| Progressive degeneration of nigrostriatal dopamine neurons following intrastriatal terminal lesions with 6-hydroxydopamine: a combined retrograde tracing and immunocytochemical study in the rat. | Q48170542 | ||
| Passage of vasoactive intestinal peptide across the blood–brain barrier | Q48317407 | ||
| An automated rotarod method for quantitative drug-free evaluation of overall motor deficits in rat models of parkinsonism | Q48560559 | ||
| Age-related effects of interleukin-1 beta on polymorphonuclear neutrophil-dependent increases in blood-brain barrier permeability in rats | Q48776274 | ||
| Function recovery following neural transplantation of embryonic septal nuclei in adult rats with septohippocampal lesions | Q48872256 | ||
| BDNF attenuates the effects of intrastriatal injection of 6-hydroxydopamine | Q72030743 | ||
| P275 | copyright license | Creative Commons CC0 License | Q6938433 |
| P6216 | copyright status | copyrighted, dedicated to the public domain by copyright holder | Q88088423 |
| P433 | issue | 9 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | macrophage | Q184204 |
| Parkinson's disease | Q11085 | ||
| P304 | page(s) | e106867 | |
| P577 | publication date | 2014-01-01 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | GDNF-transfected macrophages produce potent neuroprotective effects in Parkinson's disease mouse model | |
| P478 | volume | 9 |
| Q36969493 | A Low Protein Binding Cationic Poly(2-oxazoline) as Non-Viral Vector |
| Q39412033 | Anti-Inflammatory Modulation of Microglia via CD163-Targeted Glucocorticoids Protects Dopaminergic Neurons in the 6-OHDA Parkinson's Disease Model. |
| Q46193686 | Biological roles and potential applications of immune cell-derived extracellular vesicles |
| Q42373508 | Clodronate Improves Survival of Transplanted Hoxb8 Myeloid Progenitors with Constitutively Active GMCSFR in Immunocompetent Mice |
| Q38737886 | Development and regulation of exosome-based therapy products |
| Q33649005 | Emerging role of exosome-mediated intercellular communication in vascular remodeling |
| Q37603356 | Emerging roles of extracellular vesicles in neurodegenerative disorders: focus on HIV-associated neurological complications |
| Q38947856 | Exosomes: From Functions in Host-Pathogen Interactions and Immunity to Diagnostic and Therapeutic Opportunities |
| Q64247805 | Exosomes: biogenesis, biologic function and clinical potential |
| Q64251799 | Extracellular Vesicles as Biological Shuttles for Targeted Therapies |
| Q41605967 | Extracellular Vesicles in Brain Tumors and Neurodegenerative Diseases |
| Q90376894 | Functional equivalence of stem cell and stem cell-derived extracellular vesicle transplantation to repair the irradiated brain |
| Q52721898 | GDNF-expressing macrophages mitigate loss of dopamine neurons and improve Parkinsonian symptoms in MitoPark mice. |
| Q97549564 | Genetically modified macrophages accomplish targeted gene delivery to the inflamed brain in transgenic Parkin Q311X(A) mice: importance of administration routes |
| Q36279045 | Horizontal gene transfer from macrophages to ischemic muscles upon delivery of naked DNA with Pluronic block copolymers |
| Q36443635 | Lentivirus-mediated Persephin over-expression in Parkinson's disease rats |
| Q47824357 | Macrophage exosomes as natural nanocarriers for protein delivery to inflamed brain. |
| Q38898549 | Macrophage-based cell therapies: The long and winding road |
| Q48001748 | Macrophages with cellular backpacks for targeted drug delivery to the brain. |
| Q45304134 | Mutant Huntingtin Inhibits αB-Crystallin Expression and Impairs Exosome Secretion from Astrocytes |
| Q38879533 | Neuropharmacologic Approaches to Restore the Brain's Microenvironment. |
| Q92345091 | Non-toxic HSC Transplantation-Based Macrophage/Microglia-Mediated GDNF Delivery for Parkinson's Disease |
| Q27301281 | Noninvasive, Targeted, and Non-Viral Ultrasound-Mediated GDNF-Plasmid Delivery for Treatment of Parkinson's Disease. |
| Q59136331 | Outside in: Unraveling the Role of Neuroinflammation in the Progression of Parkinson's Disease |
| Q47332672 | Personalized nanomedicine for CNS diseases. |
| Q52937545 | Prescription for a pharmacyte. |
| Q41228349 | Progression of pathology in PINK1-deficient mouse brain from splicing via ubiquitination, ER stress, and mitophagy changes to neuroinflammation |
| Q38274179 | T-cell-mediated regulation of neuroinflammation involved in neurodegenerative diseases |
| Q38930951 | The Exosome - A Naturally Secreted Nanoparticle and its Application to Wound Healing. |
| Q28265872 | Using exosomes, naturally-equipped nanocarriers, for drug delivery |
Search more.